ArticleGenome announcements2015
Genome Sequence of a Carbapenem-Resistant Strain of Ralstonia mannitolilytica.
Article in Genome announcements, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- UnveilingAntibiotics (Basel, Switzerland) · 2025Article
- Complete sequence of carbapenem-resistantMicrobiology spectrum · 2024Article
- Bioinformatic Analysis Reveals the Role of Translation Elongation Efficiency Optimisation in the Evolution ofBiology · 2023Article
- Clinical Manifestation ofJournal of Korean medical science · 2023Article
- Spherical pneumonia caused by Ralstonia mannitolilytica: a case report and literature review.BMC pulmonary medicine · 2023Review
- Antimicrobial Treatment on a Catheter-Related Bloodstream Infection (CRBSI) Case Due to Transition of a Multi-Drug-ResistantAntibiotics (Basel, Switzerland) · 2022Article
- Article
- Longitudinal changes in the nasopharyngeal resistome of South African infants using shotgun metagenomic sequencing.PloS one · 2020Article
- Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa.BMC infectious diseases · 2019Article
- Characterization of CRISPR-Cas systems in the Ralstonia solanacearum species complex.Molecular plant pathology · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ralstonia mannitolilytica, a Gram-negative aerobic bacterium, is an opportunistic human pathogen that is becoming more common in cases of nosocomial infections. We report for the first time the whole-genome sequence analysis of R. mannitolilytica strain MRY14-0246, which carries the intrinsic OXA-443/OXA-22-like and OXA-444/OXA-60-like β-lactamase genes and is resistant to meropenem.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.